46,255 Shares in Aveanna Healthcare Holdings Inc. $AVAH Acquired by Legal & General Group Plc

Legal & General Group Plc acquired a new position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 46,255 shares of the company’s stock, valued at approximately $396,000.

Other institutional investors also recently bought and sold shares of the company. AQR Capital Management LLC increased its position in shares of Aveanna Healthcare by 21.2% in the first quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock valued at $142,000 after buying an additional 4,602 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in Aveanna Healthcare by 8.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 339,853 shares of the company’s stock valued at $1,842,000 after acquiring an additional 25,974 shares during the last quarter. Jane Street Group LLC grew its stake in Aveanna Healthcare by 522.0% in the 1st quarter. Jane Street Group LLC now owns 75,081 shares of the company’s stock valued at $407,000 after acquiring an additional 63,010 shares during the last quarter. Creative Planning increased its holdings in Aveanna Healthcare by 15.1% during the 2nd quarter. Creative Planning now owns 47,025 shares of the company’s stock valued at $246,000 after acquiring an additional 6,171 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its holdings in Aveanna Healthcare by 65.0% during the 2nd quarter. JPMorgan Chase & Co. now owns 158,265 shares of the company’s stock valued at $828,000 after acquiring an additional 62,348 shares in the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on AVAH shares. Barclays increased their price target on shares of Aveanna Healthcare from $9.50 to $15.00 and gave the company an “overweight” rating in a research report on Friday, August 28th. Truist Financial upped their target price on Aveanna Healthcare from $11.00 to $15.00 and gave the company a “hold” rating in a research note on Monday, August 24th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Thursday, July 2nd. UBS Group raised their price target on Aveanna Healthcare from $8.00 to $13.00 and gave the stock a “neutral” rating in a research report on Friday, August 14th. Finally, Wall Street Zen cut Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 15th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, Aveanna Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $13.50.

Insider Buying and Selling at Aveanna Healthcare

In related news, insider Edwin C. Reisz sold 50,000 shares of the stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $11.50, for a total transaction of $575,000.00. Following the transaction, the insider directly owned 1,397,897 shares in the company, valued at approximately $16,075,815.50. This represents a 3.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, major shareholder J.H. Whitney Equity Partners V sold 2,250,000 shares of the firm’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $11.50, for a total value of $25,875,000.00. Following the completion of the sale, the insider directly owned 12,315,892 shares in the company, valued at approximately $141,632,758. The trade was a 15.45% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 59,904,505 shares of company stock valued at $649,301,514. 5.30% of the stock is currently owned by insiders.

Aveanna Healthcare Stock Performance

Shares of AVAH opened at $13.66 on Wednesday. Aveanna Healthcare Holdings Inc. has a 1 year low of $5.93 and a 1 year high of $14.00. The company’s 50 day simple moving average is $10.89 and its 200 day simple moving average is $8.40. The company has a market capitalization of $2.98 billion, a price-to-earnings ratio of 11.11, a PEG ratio of 0.85 and a beta of 1.97. The company has a debt-to-equity ratio of 4.47, a quick ratio of 1.16 and a current ratio of 1.16.

Aveanna Healthcare (NASDAQ:AVAH) last released its earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.17 by $0.05. The firm had revenue of $670.48 million during the quarter, compared to analysts’ expectations of $638.61 million. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. On average, sell-side analysts predict that Aveanna Healthcare Holdings Inc. will post 0.75 EPS for the current year.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.